SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Antex Biologics (ANTX)
ANTX 1.080-0.9%Dec 30 3:55 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Joinvestor who wrote (1155)2/1/1999 8:08:00 PM
From: Amigo Mike  Read Replies (1) of 1476
 
Hi Jo,

Yes the stock has do very well for the month of January. There is no hooting and hollering here because Antex is relatively unknown to investing public and the investors here presently are in for the long haul and have been for some time.

As for the recent rise in share price ..... several factors are contributing to the rise.
1. Recent on success of Phase I H Pylori.
2. Mgmt efforts to increase shareholder value through the removal of Blair's options. Overhang no longer a hindrance to steady upward movement in the stock price.
3. New patents issued.
4. News of Smithkline funding for next year and milestone payment received from Pasteur.
5. More news on the horizon and updates to website forthcoming.

Amigo Mike
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext